Table 2.

Patients Eligible for Treatment Based on Screening Strategy (Mean ± SEM unless otherwise indicated)

	Total	Clinical Fracture ┼	Clinical Fracture or BMD ⧧	Clinical Fracture, BMD or Vertebral Fracture &	FRAX-FNΔ	FRAX-BMI#	Clinical Fracture or Heel Ultrasound γ
Age (Years)	85.4±0.4	85.8±0.8	86.5±0.4	86.6±0.4	86.1±0.4	85.7±0.4	87.7±0.6
BMI (Kg/m2)	27.6±0.4	27.4±0.9	26.5±0.4	26.8±0.4	26.8±0.4	27.4±0.4	25.8±0.7
Spine T-score	−0.7±0.1	−1.3±0.3	−1.5±0.2	−1.0±0.2	−1.1±0.1	−0.8±0.1	−1.6±0.3
Total Hip T-Score	−2.0±0.1	−2.3±0.2	−2.7±0.1	−2.3±0.1	−2.3±0.1	−2.0±0.1	−2.9±0.1
Femoral Neck T-Score	−2.1±0.1	−2.5±0.2	−2.8±0.1	−2.3±0.1	−2.4±0.1	−2.1±0.1	−2.8±0.2

^⧧ BMD (bone mineral density) classified by spine, total hip or femoral neck, T-score ≤ −2.5

^┼ Clinical fractures: spine or hip fragility fracture

^& Vertebral fracture identified by DXA-derived by vertebral fracture assessment or x-ray

^Δ FRAX-FN: uses femoral neck BMD with 10 year major osteoporotic fracture risk ≥ 20%, hip fracture risk ≥ 3%

^# FRAX-BMI: uses BMI without femoral neck BMD with 10 year major osteoporotic fracture risk ≥ 20%, hip fracture risk ≥ 3%

^γHeel ultrasound, T-score ≤ −2.5